External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology ATA 2023
Roche and Genentech at

ATA 2023

September 27 - October 01
Washington, USA
2023-annual-meeting
Add to calendar
Share feedback
Share page
-
Medical Materials
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Sep 29 / Roche and Genentech
Supplementary Material: Prevalence of Thyroid Eye Disease in the US: A Real-World Data Study
Thyroid eye disease (TED) is a rare, autoimmune, inflammatory ocular disorder that is potentially sight-threatening, disfiguring, and debilitating. This retrospective observational study determined annual TED prevalence and demographic distribution using an employer-based insurance claims database, IQVIA PharMetrics® Plus. Estimated US prevalence of TED between 2016–2020 suggests TED is rare, affecting less than 200,000 people in the United States. TED prevalence was nearly 4 times higher in females than males and approximately 7 times higher in adults than children.
Ophthalmology Thyroid eye disease ATA-2023

Sign up or login to unlock the full suite of MEDICALLY features
Sep 29 / Roche and Genentech
Prevalence of Thyroid Eye Disease in the US: A Real-World Data Study
Thyroid eye disease (TED) is a rare, autoimmune, inflammatory ocular disorder that is potentially sight-threatening, disfiguring, and debilitating. This retrospective observational study determined annual TED prevalence and demographic distribution using an employer-based insurance claims database, IQVIA PharMetrics® Plus. Estimated US prevalence of TED between 2016–2020 suggests TED is rare, affecting less than 200,000 people in the United States. TED prevalence was nearly 4 times higher in females than males and approximately 7 times higher in adults than children.
Ophthalmology Thyroid eye disease ATA-2023

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.